Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

microRNAs and long non‐coding RNAs as biomarkers for polycystic ovary syndrome

6 Jan 2022

Abstract excerpt

Polycystic ovary syndrome (PCOS) is known as the most common metabolic/endocrine disorder among women of reproductive age. Its complicated causality assessment and diagnostic emphasized the role of non-coding regulatory RNAs as molecular biomarkers in studying, diagnosing and even as therapeutics of PCOS. This review discusses a comparative summary of research into microRNAs (miRNAs) and long non-coding RNAs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Circular RNAs in diseases
Share to Ovarian function and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34989136
DOI: 10.1111/jcmm.17139

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

microRNAs and long non‐coding RNAs as biomarkers for polycystic ovary syndromePMID 34989136Read ↗

The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature ReviewSemantic proximity Read ↗

Role of microRNA in the Pathogenesis of Polycystic Ovary SyndromeSemantic proximity Read ↗

MicroRNAs as Biomarkers for Metabolic Disorders in Polycystic Ovary Syndrome (PCOS): A ReviewSemantic proximity Read ↗

Evaluation of circulating microRNA profiles in Brazilian women with polycystic ovary syndrome: A preliminary studySemantic proximity Read ↗

miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A reviewSemantic proximity Read ↗

Circular RNAs: Emerging Modulators in the Pathophysiology of Polycystic Ovary Syndrome and their Clinical ImplicationsSemantic proximity Read ↗

Circulating microRNAs in patients with polycystic ovary syndromeSemantic proximity Read ↗

Molecular diagnosis of polycystic ovary syndrome in obese and non-obese women by targeted plasma miRNA profilingSemantic proximity Read ↗

A glance into the roles of microRNAs (exosomal and non-exosomal) in polycystic ovary syndromeSemantic proximity Read ↗

LncRNA NEAT1 and MALAT1 are involved in polycystic ovary syndrome pathogenesis by functioning as competing endogenous RNAs to control the expression of PCOS-related target genesSemantic proximity Read ↗

The physiological functions and therapeutic potential of exosomes during the development and treatment of polycystic ovary syndromeSemantic proximity Read ↗

Increased MicroRNA Levels in Women With Polycystic Ovarian Syndrome but Without Insulin Resistance: A Pilot Prospective StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.